Changing Cross-Reactivity for Different Immunoassays Using the Same Antibodies: Theoretical Description and Experimental Confirmation
Source abstract
Abstract
Many applications of immunoassays involve the possible presence of structurally similar compounds that bind with antibodies, but with different affinities. In this regard, an important characteristic of an immunoassay is its cross-reactivity: the possibility of detecting various compounds in comparison with a certain standard. Based on cross-reactivity, analytical systems are assessed as either high-selective (responding strictly to a specific compound) or low-selective (responding to a number of similar compounds). The present study demonstrates that cross-reactivity is not an intrinsic characteristic of antibodies but can vary for different formats of competitive immunoassays using the same antibodies. Assays with sensitive detection of markers and, accordingly, implementation at low concentrations of antibodies and modified (competing) antigens are characterized by lower cross-reactivities and are, thus, more specific than assays requiring high concentrations of markers and interacting reagents. This effect was confirmed by both mathematical modeling and experimental comparison of an enzyme immunoassay and a fluorescence polarization immunoassay of sulfonamides and fluoroquinolones. Thus, shifting to lower concentrations of reagents decreases cross-reactivities by up to five-fold. Moreover, the cross-reactivities are changed even in the same assay format by varying the ratio of immunoreactants’ concentrations and shifting from the kinetic or equilibrium mode of the antigen-antibody reaction. The described patterns demonstrate the possibility of modulating immunodetection selectivity without searching for new binding reactants.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Advanced Biosensing Techniques and Applications · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
A.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia
Department of Chemical Enzymology, Chemical Faculty, M.V. Lomonosov Moscow State University, Moscow 119234, Russia
Funding
Russian Science Foundation
References (65)
Show source-provided references
1. Immunochemical techniques for multianalyte analysis of chemical residues in food and the environment: A review10.1016/j.trac.2016.12.010 ↗
2. Consumer-friendly food allergen detection: Moving towards smartphone-based immunoassays10.1007/s00216-018-0989-7 ↗
3. Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape10.1016/j.bios.2020.112454 ↗
4. Tiwari, A., and Nordin, A.N. (2014). Efficiency of biosensors as new generation of analytical approaches at the biochemical diagnostics of diseases. Advanced Biomaterials and Biodevices, Scrivener Publishing.10.1002/9781118774052 ↗
5. Detection platforms for point-of-care testing based on colorimetric, luminescent and magnetic assays: A review10.1016/j.talanta.2019.04.054 ↗
6. Paper-based immunosensors: Current trends in the types and applied detection techniques10.1016/j.trac.2018.09.027 ↗
7. Cavalera, S., Di Nardo, F., Forte, L., Marinoni, F., Chiarello, M., Baggiani, C., and Anfossi, L. (2020). Switching from multiplex to multimodal colorimetric lateral flow immunosensor. Sensors, 20.10.3390/s20226609 ↗
8. Wild, D. (2013). The Immunoassay Handbook. Theory and Applications of Ligand Binding, ELISA and Related Techniques, Elsevier Science. [4th ed.].
9. Komisarenko, S. (2013). Modern techniques of immunochemical analysis: Integration of sensitivity and rapidity. Biochemistry and Biotechnology for Modern Medicine, Publishing House Moskalenko O.M.
10. O’Kennedy, R., and Murphy, C. (2017). An overview of immunoassays. Immunoassays: Development, Applications and Future Trends, Pan Stanford Publishing Pte Ltd.10.1201/9781315206547 ↗
11. Interference in immunoassay10.1177/000456329903600603 ↗
12. Diamandis, E.D., and Christopoulos, T.K. (1996). Interferences in Immunoassay. Immunoassay, Academic Press. Chapter 7.10.1016/B978-012214730-2/50015-7 ↗
13. Improving an immunoassay response to related polychlorinated biphenyl analytes by mixing antibodies10.1021/ac0605187 ↗
14. Improved enzyme immunoassay for group-specific determination of penicillins in milk10.1080/09540100400003493 ↗
15. Development of a group-specific immunoassay for sulfonamides—Application to bee honey analysis10.1016/j.talanta.2006.05.073 ↗
16. A sensitive and group-specific monoclonal antibody-based indirect competitive ELISA for the determination of salbutamol in swine meat and liver samples10.1039/C7AY01628J ↗
17. Hemagglutinin quantitative ELISA-based potency assay for trivalent seasonal influenza vaccine using group-specific universal monoclonal antibodies10.1038/s41598-019-56169-5 ↗
18. Immunoassay development for the class-specific assay for types I and II pyrethroid insecticides in water samples10.3390/molecules15010164 ↗
19. Development of immunoassays for type II synthetic pyrethroids. 1. Hapten design and application to heterologous and homologous assays10.1021/jf970438r ↗
20. Use of biotin-streptavidin system for developing a viable, sensitive and specific antigen heterologous assay for hapten10.1016/j.talanta.2008.06.009 ↗
21. Development of a Mab-based heterologous immunoassay for the broad-selective determination of organophosphorus pesticides10.1021/jf904575k ↗
22. Development of a highly sensitive and specific immunoassay for enrofloxacin based on heterologous coating haptens10.1016/j.aca.2014.02.043 ↗
23. Heterologous antigen selection of camelid heavy chain single domain antibodies against tetrabromobisphenol A10.1021/ac5017437 ↗
24. Burkin, M.A., Galvidis, I.A., and Eremin, S.A. (2019). Specific and generic immunorecognition of glycopeptide antibiotics promoted by unique and multiple orientations of hapten. Biosens. Basel, 9.10.3390/bios9020052 ↗
25. Combined heterologies for monoclonal antibody-based immunoanalysis of fluxapyroxad10.1039/C8AN01771A ↗
26. Forcing immunoassay for sulfonamides to higher sensitivity and broader detection spectrum by site heterologous hapten inducing affinity improvement10.1039/c3ay40864g ↗
27. Effect of competitor design on immunoassay specificity: Development and evaluation of an enzyme-linked immunosorbent assay for 2,4-dinitrophenol10.1016/S0003-2670(98)00826-5 ↗
28. Broad-specificity ELISA with a heterogeneous strategy for sensitive detection of microcystins and nodularin10.1016/j.toxicon.2019.12.003 ↗
29. Immunoassay for phenylurea herbicides: Application of molecular modeling and quantitative structure-activity relationship analysis on an antigen-antibody interaction study10.1021/ac200227v ↗
30. Investigation of antigen-antibody interactions of sulfonamides with a monoclonal antibody in a fluorescence polarization immunoassay using 3D-QSAR models10.3390/ijms13056334 ↗
31. Buglak, A.A., Shanin, I.A., Eremin, S.A., Lei, H.T., Li, X.M., Zherdev, A.V., and Dzantiev, B.B. (2019). Ciprofloxacin and clinafloxacin antibodies for an immunoassay of quinolones: Quantitative structure-activity analysis of cross-reactivities. Intern. J. Mol. Sci., 20.10.3390/ijms20020265 ↗
32. Application of quantitative structure-activity relationship analysis on an antibody and alternariol-like compounds interaction study10.1002/jmr.2776 ↗
33. Waters, A.M., Ozkan-Dagliyan, I., Vaseva, A.V., Fer, N., Strathern, L.A., Hobbs, G.A., Tessier-Cloutier, B., Gillette, W.K., Bagni, R., and Whiteley, G.R. (2017). Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies. Sci. Signal., 10.10.1126/scisignal.aao3332 ↗
34. Switching antibody specificity through minimal mutation10.1016/j.jmb.2008.01.069 ↗
35. Development and comparative study of different immunoenzyme techniques for pesticides detection10.1080/03067319608045546 ↗
36. Development of a highly sensitive direct competitive fluorescence enzyme immunoassay based on a nanobody–alkaline phosphatase fusion protein for detection of 3-phenoxybenzoic acid in urine10.1021/acs.jafc.8b04521 ↗
37. Interference of 6 beta-hydroxycortisol in the quantitation of urinary free cortisol by immunoassay and its elimination by solid phase extraction10.1016/S0009-9120(98)00025-3 ↗
38. Sulea, T., Rohani, N., Baardsnes, J., Corbeil, C.R., Deprez, C., Cepero-Donates, Y., Robert, A., Schrag, J.D., Parat, M., and Duchesne, M. (2020). Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment. MABS, 12.10.1080/19420862.2019.1682866 ↗
39. Determination of the cross-reactivities of immunoassays: Effect of common cross-reactants for chlorpyrifos-ethyl in water matrices using magnetic particle-based ELISA10.1021/es950630e ↗
40. Simple method to reduce interference from excess magnesium in cadmium immunoassays10.1021/jf8011147 ↗
41. Cross-reactivity studies and predictive modeling of “Bath Salts” and other amphetamine-type stimulants with amphetamine screening immunoassays10.3109/15563650.2013.768344 ↗
42. Importance of polar solvation for cross-reactivity of antibody and its variants with steroids10.1021/jp201538t ↗
43. Enhanced specificity for small molecules in a convenient format which removes a limitation of competitive immunoassay10.1016/S0022-1759(96)00182-2 ↗
44. Improved detection sensitivity and selectivity attained by open-sandwich selection of an anti-estradiol antibody10.2116/analsci.28.861 ↗
45. Interferences in immunoassay
46. A general strategy to control antibody specificity against targets showing molecular and biological similarity: Salmonella case study10.1038/s41598-020-75285-1 ↗
47. Cross-reactivity of Aspergillus, Penicillium, and Stachybotrys antigens using affinity-purified antibodies and immunoassay10.3200/AEOH.59.5.256-265 ↗
48. An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule10.1016/0014-5793(95)00062-E ↗
49. Mathematical modeling of bioassays
50. A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein− protein interactions by fluorescence polarization10.1021/bi048233g ↗
51. Generalized mathematical model for immunoassay interference10.1016/j.autrev.2020.102663 ↗
52. Bitas, D., Kabir, A., Locatelli, M., and Samanidou, V. (2018). Food sample preparation for the determination of sulfonamides by high-performance liquid chromatography: State-of-the-art. Separations, 5.10.3390/separations5020031 ↗
53. Gold immunochromatographic sensor for the rapid detection of twenty-six sulfonamides in foods10.1007/s12274-017-1490-x ↗
54. Production of polyclonal antibodies and development of fluorescence polarization immunoassay for sulfanilamide10.1081/AL-200054059 ↗
55. A new generic enzyme immunoassay for sulfonamides10.1080/00032710701296945 ↗
56. Development of a polarization fluoroimmunoassay for the herbicide metsulfuron-methyl10.1080/09540100220145000d ↗
57. Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays10.1006/meth.2000.1031 ↗
58. Monoclonal antibodies requiring coating buffer with low pH for efficient antigen capture in sandwich ELISA: The rarities or practically important phenomena?10.1080/15321819.2013.764894 ↗
59. Immobilization of unraveled immunoglobulin G using well-oriented ZZ–His protein on functionalized microtiter plate for sensitive immunoassay10.1016/j.ab.2012.09.028 ↗
60. Ahmed, M.U., Zourob, M., and Tamiya, E. (2019). Introduction to Immunosensors. Immunosensors, Royal Chemical Society.10.1039/9781788016162 ↗
61. Label and label-free detection techniques for protein microarrays10.3390/microarrays4020228 ↗
62. Iglesias-Mayor, A., Amor-Gutiérrez, O., Costa-García, A., and de la Escosura-Muñiz, A. (2019). Nanoparticles as emerging labels in electrochemical immunosensors. Sensors, 19.10.3390/s19235137 ↗
63. Nanomaterials for molecular signal amplification in electrochemical nucleic acid biosensing: Recent advances and future prospects for point-of-care diagnostics10.1039/C9ME00135B ↗
64. Cajigas, S., and Orozco, J. (2020). Nanobioconjugates for signal amplification in electrochemical biosensing. Molecules, 25.10.3390/molecules25153542 ↗
65. Methods for increasing sensitivity of immunochromatographic test systems with colorimetric detection (review)10.1134/S0003683821020113 ↗